MARKER THERAPEUTICS, INC. Stock Split Ratio
MARKER THERAPEUTICS, INC. (MRKR) reported Stock Split Ratio of 1200.00% for the 0-month period ending 2016-09-16, per its 10-Q filed 2016-11-04.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2016-11-04
- 2016-09-16: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 1200.00%.
- 2014-02-18: Stockholders' Equity Note, Stock Split, Conversion Ratio 10000.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|---|
| 2016-09-16 | 1200.00% 10-Q · filed 2016-11-04 | |
| 2014-02-18 | 10000.00% 10-K · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |